BlackRock Fund Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$227M Buy
2,876,375
+280,803
+11% +$21.8M 0.04% 549
2016
Q3
$202M Buy
2,595,572
+180,677
+7% +$13.1M 0.04% 531
2016
Q2
$166M Buy
2,414,895
+135,506
+6% +$9.35M 0.04% 611
2016
Q1
$163M Sell
2,279,389
-16,418
-0.7% -$1.03M 0.04% 597
2015
Q4
$143M Buy
2,295,807
+104,240
+5% +$6.36M 0.03% 691
2015
Q3
$124M Buy
2,191,567
+66,844
+3% +$3.54M 0.03% 746
2015
Q2
$114M Buy
2,124,723
+592
+0% +$28.8K 0.03% 882
2015
Q1
$101M Buy
2,124,131
+122,281
+6% +$5.41M 0.02% 996
2014
Q4
$86.6M Buy
2,001,850
+174,790
+10% +$7.14M 0.02% 1057
2014
Q3
$62.8M Buy
1,827,060
+16,901
+0.9% +$597K 0.02% 1202
2014
Q2
$66.3M Sell
1,810,159
-77,537
-4% -$2.63M 0.02% 1212
2014
Q1
$63.7M Buy
1,887,696
+40,235
+2% +$1.33M 0.02% 1224
2013
Q4
$62.6M Sell
1,847,461
-60,949
-3% -$2.11M 0.02% 1218
2013
Q3
$60.8M Buy
1,908,410
+217,356
+13% +$5.78M 0.02% 1170
2013
Q2
$38.2M Buy
+1,691,054
New +$36.6M 0.01% 1419

Other funds holding CMD

BlackRock Fund Advisors's CMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Cantel Medical Corporation (CMD) stake by 11% in Q4 2016, buying an estimated $21.8M and bringing the position to 2,876,375 shares worth $227M. The position accounts for 0.04% of the portfolio, ranked #549.

BlackRock Fund Advisors first reported a position in CMD in Q2 2013 and has held it in 15 quarters since. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

  • BlackRock Fund Advisors held 2,876,375 shares of Cantel Medical Corporation worth $227M as of Q4 2016.
  • BlackRock Fund Advisors bought 280,803 Cantel Medical Corporation shares in Q4 2016, an estimated $21.8M.
  • Cantel Medical Corporation made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #549 holding.
  • BlackRock Fund Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 15 quarters since.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.